基于真实世界中医电子病历的慢性萎缩性胃炎亚群识别
研究收集6253份慢性萎缩性胃炎患者的中医临床电子病历,最终纳入5132例患者,通过症状-患者相似网络与社区发现方法将人群划分为176个模块,并选取前3个模块分析其临床特征与用药对应关系。结果显示不同亚群在症状表现和常用中药上存在差异,并可通过网络药理学提示潜在信号通路,为临床个体化治疗提供参考。
要点
- 基于5132例患者数据可划分出多个CAG临床亚群,各亚群症状与用药特征不同。
- M29亚群以胃痞、浊毒内蕴为特征,常用中药包括佛手、龙葵、僵蚕、山慈菇等。
- M3亚群以胃脘痛、肝胃不和为特征,常用中药包括土茯苓、香附、当归等。
核心结论
- 基于症状-患者相似网络识别和社区检测分析对CAG人群进行划分,可为临床CAG治疗提供有用建议。
研究设计与样本
- 研究收集6253份CAG患者的中医临床电子病历,经手工标注、提取和预处理后,最终纳入5132例患者进行分析。
- 纳入患者中男性2699例(52.60%),女性2433例(47.41%)。
- 构建共享症状-患者相似网络,采用社区识别方法建立CAG患者亚组,并通过富集分析确定其临床特征。
主要发现
- 人群被划分为176个模块,研究选取前3个模块(M29、M3、M0)说明CAG疾病亚群的特征表型和基因型。
- M29亚群以胃痞病和浊毒内蕴为特征,M3亚群以胃脘痛和肝胃不和为特征,M0亚群以胃脘痛和湿热证为特征。
- 三个亚群中症状改善最多的前几位症状均为胃痛、腹胀、失眠、食欲不振和烧心,但各组间存在差异。
关键数值与推荐
- M29亚群更易出现胃胀、厌食和心悸,最常用的中药为佛手、龙葵、僵蚕、山慈菇和 Dillon。
- M3亚群尿黄、口苦和胃痛发生率较高,常用中药为土茯苓、香附、当归、藁本和芍药。
- M0亚群常见呕吐、恶心、胃痛和食欲丧失,主要用药为黄芩、土茯苓、胡黄连、百合和茵陈。
临床怎么用
- 可根据CAG患者症状特征将其归入不同亚群,参考相应亚群的常用中药进行个体化治疗。
- 对以胃痞、浊毒内蕴为主者参考M29亚群用药,对以胃脘痛、肝胃不和为主者参考M3亚群用药。
- 对以胃脘痛、湿热证为主者参考M0亚群用药,并结合症状改善情况调整。
局限性
- 研究基于中医电子病历数据,亚群划分和用药对应关系需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Chronic atrophic gastritis (CAG) is a complex chronic disease caused by multiple factors that frequently occurs disease in the clinic. The worldwide prevalence of CAG is high. Interestingly, clinical CAG patients often present with a variety of symptom phenotypes, which makes it more difficult for clinicians to treat. Therefore, there is an urgent need to improve our understanding of the complexity of the clinical CAG population, obtain more accurate disease subtypes, and explore the relationship between clinical symptoms and medication. Therefore, based on the integrated platform of complex networks and clinical research, we classified the collected patients with CAG according to their different clinical characteristics and conducted correlation analysis on the classification results to identify more accurate disease subtypes to aid in personalized clinical treatment. METHOD: Traditional Chinese medicine (TCM) offers an empirical understanding of the clinical subtypes of complicated disorders since TCM therapy is tailored to the patient's symptom profile. We gathered 6,253 TCM clinical electronic medical records (EMRs) from CAG patients and manually annotated, extracted, and preprocessed the data. A shared symptom-patient similarity network (PSN) was created. CAG patient subgroups were established, and their clinical features were determined through enrichment analysis employing community identification methods. Different clinical features of relevant subgroups were correlated based on effectiveness to identify symptom-botanical botanical drugs correspondence. Moreover, network pharmacology was employed to identify possible biological relationships between screened symptoms and medications and to identify various clinical and molecular aspects of the key subtypes using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. RESULTS: 5,132 patients were included in the study: 2,699 males (52.60%) and 2,433 females (47.41%). The population was divided into 176 modules. We selected the first 3 modules (M29, M3, and M0) to illustrate the characteristic phenotypes and genotypes of CAG disease subtypes. The M29 subgroup was characterized by gastric fullness disease and internal syndrome of turbidity and poison. The M3 subgroup was characterized by epigastric pain and disharmony between the liver and stomach. The M0 subgroup was characterized by epigastric pain and dampness-heat syndrome. In symptom analysis, The top symptoms for symptom improvement in all three subgroups were stomach pain, bloating, insomnia, poor appetite, and heartburn. However, the three groups were different. The M29 subgroup was more likely to have stomach distention, anorexia, and palpitations. Citrus medica, Solanum nigrum, Jiangcan, Shan ci mushrooms, and Dillon were the most popular botanical drugs. The M3 subgroup has a higher incidence of yellow urine, a bitter tongue, and stomachaches. Smilax glabra, Cyperus rotundus, Angelica sinensis, Conioselinum anthriscoides, and Paeonia lactiflora were the botanical drugs used. Vomiting, nausea, stomach pain, and appetite loss are common in the M0 subgroup. The primary medications are Scutellaria baicalensis, Smilax glabra, Picrorhiza kurroa, Lilium lancifolium, and Artemisia scoparia. Through GO and KEGG pathway analysis, We found that in the M29 subgroup, Citrus medica, Solanum nigrum, Jiangcan, Shan ci mushrooms, and Dillon may exert their therapeutic effects on the symptoms of gastric distension, anorexia, and palpitations by modulating apoptosis and NF-κB signaling pathways. In the M3 subgroup, Smilax glabra, Cyperus rotundus, Angelica sinensis, Conioselinum anthriscoides, and Paeonia lactiflora may be treated by NF-κB and JAK-STAT signaling pathway for the treatment of stomach pain, bitter mouth, and yellow urine. In the M0 subgroup, Scutellaria baicalensis, Smilax glabra, Picrorhiza kurroa, Lilium lancifolium, and Artemisia scoparia may exert their therapeutic effects on poor appetite, stomach pain, vomiting, and nausea through the PI3K-Akt signaling pathway. CONCLUSION: Based on PSN identification and community detection analysis, CAG population division can provide useful recommendations for clinical CAG treatment. This method is useful for CAG illness classification and genotyping investigations and can be used for other complicated chronic diseases.
引用
- Wang YM, Sun JH, Sun RX, et al. Treating chronic atrophic gastritis: identifying sub-population based on real-world TCM electronic medical records. Front Pharmacol. 2024. PMID: 39170704. doi:10.3389/fphar.2024.1444733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。